Stealth BioTherapeutics (Stealth BioTherapeutics) EV-to-Revenue : (As of May. 12, 2024)

Stealth BioTherapeutics EV-to-Revenue Chart

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Stealth BioTherapeutics's EV-to-Revenue

For the Biotechnology subindustry, Stealth BioTherapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stealth BioTherapeutics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's EV-to-Revenue falls into.

Stealth BioTherapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Stealth BioTherapeutics's EV-to-Revenue for today is calculated as:

Stealth BioTherapeutics's current Enterprise Value is $3.48 Mil.
Stealth BioTherapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stealth BioTherapeutics  (NAS:MITO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Stealth BioTherapeutics's PS Ratiofor today is calculated as:

Stealth BioTherapeutics's share price for today is $0.32.
Stealth BioTherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stealth BioTherapeutics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description